tiprankstipranks

Matthias Alder Insider Profile

4 Followers
Matthias Alder, EVP, Business Dev. & Licensing at Sucampo Pharmaceuticals, holds 21.14K shares in Gain Therapeutics (Ticker: GANX), holds 936.00 shares in Sucampo Pharmaceuticals (Ticker: SCMP).
tipranks
Matthias Alder

Matthias Alder
Sucampo Pharmaceuticals (SCMP)
EVP, Business Dev. & Licensing

Ranked #29,707 out of 97,944 Corporate Insiders

Profitable Transactions

100%
2 out of 2 Profitable Transactions

Average Return

+48.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$27K
100.00%
A breakdown of Matthias Alder's holdings

Insider Roles

Gain Therapeutics
(GANX)
CEO, Director
Roles that Matthias Alder holds in companies

Most Profitable Insider Trade

Stock:
Gain Therapeutics
(GANX)
Rating:Informative Sell
Date:Dec 14, 2023 - Today
Return:+49.60%
The most profitable trade made by Matthias Alder

Matthias Alder's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SCMP
Sucampo Pharmaceuticals
Jul 07, 2017
Uninformative Buy
6.01K
$16.85K
Gain Therapeutics
Mar 28, 2024
CEO, Director
Uninformative Buy
57.36K
$27.06K
List of latest transactions for each holding click on a transaction to see Matthias Alder's performance on stock

Matthias Alder insider profile FAQ

What is the percentage of profitable transactions made by Matthias Alder?
The percentage of profitable transactions made by Matthias Alder is 100%.
    What is the average return per transaction made by Matthias Alder?
    The average return per transaction made by Matthias Alder is 48.80%.
      What stocks does Matthias Alder hold?
      Matthias Alder holds: SCMP, GANX stocks.
        What was Matthias Alder’s latest transaction?
        Matthias Alder latest transaction was an Uninformative Buy of $57.36K.
          What was Matthias Alder's most profitable transaction?
          Matthias Alder’s most profitable transaction was an Informative Sell of GANX stock on December 14, 2023. The return on the trade was 49.60%.
            What is Matthias Alder's role in Sucampo Pharmaceuticals?
            Matthias Alder's role in Sucampo Pharmaceuticals is EVP, Business Dev. & Licensing.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.